Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials (Q21092309)

From Wikidata

Jump to navigation Jump to search

scientific article

Albendazole versus Praziquantel in the Treatment of Neurocysticercosis: A Meta-analysis of Comparative Trials

Language	Label	Description	Also known as
English	Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials	scientific article	Albendazole versus Praziquantel in the Treatment of Neurocysticercosis: A Meta-analysis of Comparative Trials

Statements

scholarly article

0 references

1 reference

based on heuristic

inferred from title

Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials (English)

0 references

infectious disease

0 references

0 references

neurocysticercosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Dimitrios K. Matthaiou

1

object named as

Dimitrios K Matthaiou

author given names

Dimitrios K

author last names

Matthaiou

1 reference

15 August 2022

Matthew E. Falagas

4

object named as

Matthew E Falagas

author given names

Matthew E

author last names

Falagas

1 reference

15 August 2022

Eleni S Adamidi

3

author given names

Eleni S

author last names

Adamidi

object named as

Eleni S Adamidi

1 reference

15 August 2022

Georgios D Panos

2

author given names

Georgios

author last names

Panos

object named as

Georgios Panos

1 reference

15 August 2022

language of work or name

0 references

publication date

2008

0 references

PLoS Neglected Tropical Diseases

0 references

2

0 references

e194

0 references

3

0 references

copyright license

Creative Commons Attribution 4.0 International

12 March 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Current consensus guidelines for treatment of neurocysticercosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

19 March 2017

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

19 March 2017

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

19 March 2017

Meta-analysis in clinical trials

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

19 March 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

12 September 2017

Neurocysticercosis: a major cause of neurological disease worldwide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

19 March 2017

Cysticercosis: an emerging parasitic disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

12 September 2017

Neurocysticercosis: current knowledge and advances

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

12 September 2017

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

12 September 2017

Control of Taenia solium cysticercosis/taeniosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

12 September 2017

Meta-analysis: Methods, strengths, weaknesses, and political uses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

12 September 2017

Controlling the risk of spurious findings from meta-regression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

12 September 2017

Assessing the quality of randomized controlled trials. Current issues and future directions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

27 September 2017

The importance of quality of primary studies in producing unbiased systematic reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

27 September 2017

Drug treatment of neurocysticercosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

30 May 2018

Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

30 May 2018

Effect of anticysticercal treatment on the prognosis of epilepsy in neurocysticercosis: a pilot trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

30 May 2018

Therapy of parenchymal brain cysticercosis with praziquantel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

30 May 2018

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

30 May 2018

Albendazole versus praziquantel in the treatment of cerebral cysticercosis: clinical evaluation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

30 May 2018

Therapy for neurocysticercosis. Comparison between albendazole and praziquantel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265431

30 May 2018

Neurocysticercosis--is the elimination of parasites beneficial?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000194

21 January 2018

Single-day praziquantel versus 1-week albendazole for neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000194

21 January 2018

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000194

21 January 2018

Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000194

21 January 2018

Spontaneous radiographic disappearance of cerebral cysticercosis: three cases.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000194

21 January 2018

Single-day praziquantel therapy for neurocysticercosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18335068

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dexamethasone increases plasma levels of albendazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/18335068

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cysticercotic encephalitis: a severe form in young females

1 reference

https://pubmed.ncbi.nlm.nih.gov/18335068

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is the course of neurocysticercosis modified by treatment with antihelminthic agents?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18335068

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurocysticercosis: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/18335068

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenytoin and carbamazepine decreased oral bioavailability of praziquantel

1 reference

https://pubmed.ncbi.nlm.nih.gov/18335068

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose praziquantel for neurocysticercosis: efficacy and tolerability

1 reference

https://pubmed.ncbi.nlm.nih.gov/18335068

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy for Neurocysticercosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18335068

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PNTD.0000194

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q21092309&oldid=2017476030"